Trials / Sponsors / Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects NASH With Fibrosis | EARLY_Phase 1 | 2023-03-01 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis Nonalcoholic Steatohepatitis (NASH), Fibrosis, Liver, NAFLD | Phase 2 | 2022-10-15 |
| Completed | A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3 NASH With Fibrosis | Phase 2 | 2022-03-15 |
| Completed | A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver, NAFLD - Nonalcoholic Fatty Liver Disease | Phase 2 | 2020-06-23 |
| Completed | A Study in Healthy Volunteers Hepatitis B, Infectious Disease, Liver Diseases | Phase 1 | 2019-07-09 |